Abstract

The increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pneumonia necessitates innovative approaches for early detection and disease management. Traditional diagnostic methods, though effective, often involve delays in symptom onset, reliance on hospital visits, and diagnostic tools that may not provide continuous monitoring. This paper explores the development and potential of AI-assisted wearable devices for the early detection of respiratory diseases. These devices, equipped with advanced sensors and powered by artificial intelligence algorithms, enable real-time monitoring of key respiratory parameters such as oxygen saturation, respiratory rate, and lung function. By detecting early signs of respiratory distress, these wearable devices facilitate timely intervention and personalized care, ultimately improving patient outcomes. The research highlights these devices' design, testing, and performance in detecting exacerbations or the onset of respiratory conditions, comparing them with traditional methods such as spirometry and blood oxygen saturation tests. Key findings demonstrate that AI-assisted wearables can offer continuous, non-invasive monitoring, thereby improving diagnostic accuracy, patient engagement, and overall disease management. Furthermore, the study identifies challenges in sensor accuracy, data privacy, and device data integration into healthcare systems. The paper concludes by discussing the potential public health benefits, including reduced hospital admissions and healthcare costs, while recommending further research on sensor accuracy, algorithm improvements, and large-scale clinical trials to refine the technology and optimize its effectiveness. AI-assisted wearable devices represent a transformative advancement in respiratory disease management, significantly improving early detection, patient self-management, and healthcare accessibility.